Opportunities for life sciences companies to digitalise, and create digital technologies for personalised therapy
Patients and consumers are taking charge of their lives. They are more health-conscious and better informed. They believe in prevention rather than treatment. At the same time, life sciences companies are confronted by the twin challenges of reducing costs and enhancing patient outcomes. And all of this in the context of a sweeping wave of digitalization.
In the new life sciences ecosystem, the patient takes centre stage. Many companies are slowly beginning to understand how digitalization is absolutely instrumental in this important step. While 17 percent of respondents named ‘patient centricity’ as a current benefit of digitalization, 24 percent were of the opinion that this will be a key focus within the next five years.
This publication highlights a number of compelling, real-world examples that we hope will inspire the leaders of today’s life sciences companies. We will also share our findings from discussions with the leaders of more than 75 companies in the life sciences sector regarding their progress on their digitalization journeys.
© 2020 KPMG Huazhen LLP, a People's Republic of China partnership, KPMG Advisory (China) Limited, a limited liability company in China, KPMG, a Macau partnership and KPMG, a Hong Kong partnership, are member firms of the KPMG global organisation of independent member firms affiliated with KPMG International Limited ("KPMG International"), a private English company limited by guarantee. All rights reserved. The KPMG name and logo are registered trademarks or trademarks of KPMG International.
For more detail about the structure of the KPMG global organisation please visit https://home.kpmg/governance.